Overview
- 20 inspections across 19 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2019-03-12.
At a glance
Inspections
20
Sites
19
Observations
1
Career since
Mar 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kashiv BioSciences, LLC | 12 Mar 2019 | Human Drugs | On file |
| AbbVie Operations Singapore Pte. Ltd. | 5 Dec 2018 | Human Drugs | |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 26 Oct 2018 | Human Drugs | On file |
| Alcami Carolinas Corporation | 10 Oct 2018 | Human Drugs | On file |
| Rentschler Biopharma SE | 8 Mar 2018 | Human Drugs |
Sites inspected
Kashiv BioSciences, LLCChicago, United States1 insp.
AbbVie Operations Singapore Pte. Ltd.Singapore, Singapore1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
Alcami Carolinas CorporationCharleston, United States1 insp.
Rentschler Biopharma SELaupheim, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Shanks3 shared
Scott R Nichols2 shared
Bo Chi2 shared
Reyes Candau-Chacon2 shared
Vaishali J Patel1 shared
Ramesh B Potla1 shared
Rebecca E Dombrowski1 shared
Amy A Devlin1 shared
Laurie Nelson1 shared
V Ashutosh Rao1 shared
Full investigator report
Get the verbatim findings behind Steven Fong's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site